MicroRNA‐130a‐3p Suppresses Cell Migration and Invasion by Inhibition of TBL1XR1‐mediated EMT in Human Gastric Carcinoma

Shanshan Wang,Haibo Han,Ying Hu,Wei Yang,Yunwei Lv,Limin Wang,Lianhai Zhang,Jiafu Ji
DOI: https://doi.org/10.1002/mc.22762
2017-01-01
Molecular Carcinogenesis
Abstract:MiR‐130a‐3p was found to play tumor suppressor role in most human cancers, except for gastric cancer. However, in this study, we demonstrated that miR‐130a‐3p was significantly down‐regulated in gastric carcinoma (GC) tissues compared with adjacent non‐neoplastic tissues, and decreased miR‐130a‐3p expression was associated with shorter overall survival (OS) and was an independent prognostic factor for OS in GC patients. Over‐expression of miR‐130a‐3p remarkably inhibited not only GC cell migration, invasion, and epithelial‐mesenchymal transition (EMT) in vitro, but also tumorigenesis and lung metastasis in the chick embryo chorioallantoic membrane (CAM) assay in vivo. Conversely, inhibition of miR‐130a‐3p resulted in opposite phenotype changes in GC cells. Furthermore, TBL1XR1 was identified as a direct target of miR‐130a‐3p, and reintroduction of TBL1XR1 into miR‐130a‐3p‐transfected MGC‐803 cells reversed the inhibitory effects of miR‐130a‐3p on GC cell migration, invasion and EMT. Taken together, our data suggested that miR‐130a‐3p suppressed aggressive phenotype of GC cells partially by direct targeting and decreasing TBL1XR1 and subsequent EMT process.
What problem does this paper attempt to address?